America's Essential Hospitals called on CMS to provide an adequate annual payment update to cover the effects of inflation and rising workforce costs.

In its response to the Centers for Medicare & Medicaid Services, America's Essential Hospitals comments on policies for telehealth services, advanced diagnostic imaging, social determinants of health, and other Physician Fee Schedule proposals.

Effective Oct. 5, the State Department’s regulations will revert to the narrower definition of public charge in a 1997 State Department rule.

FDA approves Moderna and Pfizer-BioNTech's updated COVID-19 vaccines, and HHS announces $1.4 billion for Project NextGen.

The President’s Council of Advisors on Science and Technology outlines strategies to improve patient safety and reduce health care–associated injuries.

The association supports changes to the definition and duration of short-term, limited-duration insurance and requests clarification in application notices.

The States Advancing All-Payer Health Equity Approaches and Development Model focuses on chronic condition treatment and behavioral health.

CMS urges states to review their Medicaid renewal processes to ensure eligible individuals are not disenrolled erroneously through ex parte renewals at the household level.

America’s Essential Hospitals urged CMS to swiftly finalize a remedy to repay 340B hospitals for five years of Medicare Part B drug payment cuts.

The Centers for Medicare & Medicaid Services is exploring a new model to promote health equity, with the goal of enhancing access to patient-centered care for underserved groups and including them in value-based care systems.

HHS will host the Aug. 24 webinar to gather input from a variety of health care stakeholders on hospital preparedness before, during, and after emergencies.

The National Maternal Mental Health Hotline has provided support to nearly 13,400 people in its first year.

The administrative fee returns from $350 to $50 after an Aug. 3 court decision, but the independent dispute resolution portal remains closed to new disputes.

HHS announced the formation of the Office of Long COVID Research and Practice to lead the long COVID response as EG.5 subvariant cases increase.

The funding supports a program to help licensed practical nurses become registered nurses, the Nurse Faculty Loan Program, and other nurse training programs.

The National Action Alliance to Advance Patient Safety webinar, on Aug. 22, will highlight how leadership engagement can foster a culture of safety.

CMS has developed a three-step guide for state Medicaid programs to develop a claiming methodology for the differential match rate.

The letters review the state's May 2023 Medicaid unwinding metrics and compliance with federal requirements in three categories.

The toolkit aims to help states increase postpartum care access, quality, and equity by maximizing existing Medicaid authorities.

CMS suspended the independent dispute resolution process for certain surprise billing disputes due to an Aug. 3 court decision.

The rule includes changes to the calculation of Medicare disproportionate share hospital payments and payment and quality reporting provisions.

The rule aims to reinforce a law requiring that consumers have the same access to mental health and SUD benefits as they do physical health benefits.

CMS will release state Medicaid and Children's Health Insurance Program renewal data on a monthly, two-part basis due to data availability. 

Hospitals have until Sept. 11 to complete recertification for the 340B Drug Pricing Program through the Office of Pharmacy Affairs Information System.

CMS outlines three strategies to improve treatment and support for Medicaid and CHIP enrollees with mental health and substance use disorder conditions.

An August webinar series will provide strategies for reaching out to diverse communities to share information about Medicaid and CHIP renewals.

The states will implement mitigation strategies before starting procedural terminations for Medicaid beneficiaries who have not renewed.

In California and Kentucky, mobile teams can provide Medicaid services to individuals experiencing a behavioral health or substance use crisis.

A new letter warns health systems and telehealth providers that online web tracking technologies can send sensitive information to third parties.

CMS released a request for information to aid the design of a future episode-based payment model to be implemented no later than 2026.

The proposed rule would clarify and reaffirm the prohibition on discrimination on the basis of sexual orientation and gender identity in certain statutes.

The CDC Bridge Access Program will provide no-cost COVID-19 vaccines to uninsured and underinsured adults following the end of the COVID-19 Vaccine Distribution Program; the GAO released a new report outlining recommendations for future public health emergency preparedness.

The rule revises site-neutral payment policies, updates price transparency requirements, and changes outpatient quality reporting, among other provisions.

The proposed rule includes provisions for Medicare reimbursement of telehealth services, quality programs, and social determinants of health data collection.

HHS proposes to modify the definition of short-term, limited-duration insurance and conditions surrounding hospital or other fixed indemnity insurance.

The FAQ respond to concerns about the definition of cost sharing and facility fees in the No Surprises Act and Affordable Care Act.

CDC reports that roughly three-fourths of all Americans aged 16 and older had contracted COVID-19 by the end of 2022; the agency also reports new data showing the disproportionate effect of COVID-19 on the lowest-income communities.

CMS proposes to remedy five years of unlawful cuts to Medicare Part B reimbursement for separately payable drugs with lump-sum payments expected in late 2023 or early 2024.

CMS is publishing all approved state directed payment preprints on its website, along with preprint addendum tables in Excel workbook format.

The FAQ clarify the new enforcement authority in the Consolidated Appropriations Act, 2023 related to states' federal medical assistance percentage.

Starting Oct. 1, Medicaid and the Children’s Health Insurance Program will cover only COVID-19 vaccines that have been fully approved by the Food and Drug and Administration.

The association urged CMS to ensure sufficient payment rates in the Medicaid managed care and fee-for-service programs for providers in hospital settings.

The association urged an appeals court to restore an Affordable Care Act requirement that most health plans cover certain preventive services.

Moderna seeks FDA authorization for an updated vaccine, Invivyd announces a pathway to potential emergency use authorization for the monoclonal antibody adintrevimab, and the CDC tracks a new subvariant, EU.1.1.

The Medicaid and CHIP Payment and Access Commission's June report to Congress includes recommendations on countercyclical disproportionate share hospital policy and explores health care challenges faced by adults leaving incarceration.

The FDA's Vaccines and Related Biological Products Advisory Committee advises manufacturers to develop a monovalent vaccine targeting XBB, the globally dominant subvariant, in time for the fall.

A proposed rule allows certain entities exempt from federal tax, including hospitals, to 12 clean energy tax credits through the Inflation Reduction Act.

HHS offers flexible options states can adopt to ensure smooth transitions of coverage during the Medicaid redetermination process.

From July 2024 through 2034, CMMI will pilot in eight states the Making Care Primary Model, which will support value-based primary care.

The final rule retroactively affects the calculation of Medicare disproportionate share hospital payments from fiscal years 2005 to 2013.

The association urged CMS to increase the proposed annual hospital payment update and adopt a safety net hospital definition and related payment policies.

A CDC study confirms that a third mRNA vaccine is safe for children; FDA grants marketing authorization for the Cue at-home COVID-19 test.

The new group, comprising two divisions from existing groups, will monitor and provide technical assistance to state and territory managed care programs.

Two CDC studies indicate that adults who have not received a bivalent mRNA booster vaccine have little remaining protection against COVID-19–associated hospitalization and that half of Americans aged 16 and up have hybrid immunity against the virus.

CMS says the withdrawal of the mandate, effective immediately, aligns with the agency's approach to other infectious diseases.

The Food and Drug Administration approves Paxlovid to treat COVID-19 in adults; a National Institutes of Health study sheds new light on long COVID-19.

The proposed rule targets drug misclassification, along with drug pricing and product data misreporting, by manufacturers.

The report summarizes HHS' progress, barriers, and future plans to improve access to services for individuals with limited English proficiency.

A World Health Organization advisory group recommends using the XBB subvariant in future vaccines; the National Institute for Occupational Safety and Health recalls eight respirators.

A new guide provides educational and referral strategies for health care providers to mitigate health issues related to climate change.

The FAQ guide state Medicaid and Children's Health Insurance Program agencies as they begin terminating enrollment for those who no longer qualify.

An HHS fact sheet details policy changes with the end of the COVID-19 public health emergency; ASPR announces Project NextGen; CDC says the Johnson & Johnson vaccine no longer is available in the United States.

The letter expressed concern with reports that HRSA no longer will allow hospitals to administer 340B drugs in offsite outpatient locations that have not yet appeared on a filed Medicare cost report.

Health care providers will be able to prescribe controlled medication without requiring an initial in-person visit through Nov. 11.

The World Health Organization has ended the COVID-19 global health emergency designation, and the CDC will use hospitalization data to track COVID-19 spread.

The brief urges an appeals court to restore an Affordable Care Act requirement that most health plans cover certain preventive services.

After receiving record comments on proposals to limit the prescription of controlled substances via telemedicine, the DEA will extend this COVID-era flexibility.

The six new members will review Medicaid and CHIP access and payment policies and make recommendations to Congress, the administration, and states.

Hospitals have until June 1 to preview their Overall Hospital Quality Star Rating, measure group score, individual measure results, and peer grouping.

FDA amends the Pfizer vaccine authorization for immunocompromised children aged 6 months to 4 years old, while the Biden administration ends its vaccine requirement for federal employees.

The May 5 webinar will feature CMS experts sharing how the end of the PHE will affect current health care waivers and flexible policies.

Two proposed rules establish access standards and standardize review and assessment of Medicaid payment rates across states; comments are due to CMS July 3.

The association urged CMS to withdraw its proposal to exclude patient days related to uncompensated care pools from the Medicare disproportionate share hospital funding calculation.

To increase compliance with the hospital price transparency rule, CMS has set new compliance timelines and no longer will issue warning notices.

In a letter to hospital and provider associations, Secretary Becerra emphasized health care providers' legal duties to provide emergency care.

A new webinar series will share government resources for health care stakeholders to reduce emissions and build resilience.

The rule updates essential community provider requirements for qualified health plans and adds a special enrollment period for those losing Medicaid or CHIP coverage.

The rule would allow DACA recipients to be eligible for health care coverage through the Affordable Care Act marketplace, Medicaid, and the Children's Health Insurance Program.

The new tool from the federal Office of Climate Change and Health Equity explains opportunities in the Inflation Reduction Act for tax credits and other support for climate mitigation work.

The association urged CMS to work with Congress to avoid unintended cuts to Medicaid disproportionate share hospital payments imposed by Section 203.

CDC simplifies vaccine recommendations for all age groups; a new HHS program supports COVID-19 vaccines and treatments for uninsured Americans.

The Supporting Safety Net Hospitals Act would eliminate devastating cuts to Medicaid disproportionate share hospital funding in fiscal years 2024 and 2025.

Individuals ages 65 and older are eligible for a second bivalent dose; HHS will end vaccine administration flexibility granted during the public health emergency.

A new Section 1115 demonstration will support service delivery systems that facilitate reentry transitions for Medicaid-eligible individuals leaving prisons and jails.

In honor of Black Maternal Health Week, CMS shares recent work and resources focused on advancing equity in obstetric outcomes.

President Biden signs a bill ending the COVID-19 national emergency; FDA grants emergency use authorization to a vilobelimab treatment.

The proposed fiscal year 2024 Inpatient Prospective Payment System rule includes a request for feedback on defining safety net hospitals; CMS will accept comments until June 9.

A new categorical waiver allows health care facilities to use alternate power sources other than a generator or battery system.

Both the CDC and World Health Organization now recommend just one bivalent booster dose for healthy adults and children with no immunocompromising conditions.

The upcoming end of the COVID-19 national emergency will not affect policies enacted during the public health emergency issued under a separate declaration.

The report includes recommendations for therapeutic practices for youth of diverse sexual orientation and gender identity.

The state has extended postpartum coverage from 60 days to 12 months through the state plan authority established by the American Rescue Plan Act in 2021.

FDA releases guidance on transitioning to normal operations for medical device authorization after the public health emergency ends and continues to monitor the effect of viral mutation on test performance.

FDA announces that children aged 6 months through 4 years old who completed primary monovalent COVID-19 vaccination are now eligible to receive a bivalent booster dose, while agency advisers vote in favor of full Paxlovid approval.

To exclude 340B drugs from Medicare Part B inflation rebates required by the Inflation Reduction Act, providers must identify 340B drugs on Medicare claims. 

The decision comes after HHS halted payment determinations following a February court ruling vacating certain provisions of the No Surprises Act.

The guide tailors the 2018 National Institute of Standards and Technology Framework for Improving Critical Infrastructure Cybersecurity to the health sector.

The report reviews how COVID-19 public health emergency policies affected hospital finances and includes state-specific projections for the Medicaid disproportionate share hospital funding cuts scheduled to take effect Oct. 1.

Per the Inflation Reduction Act, drug manufacturers that increase prices faster than the inflation rate will be required to pay rebates to Medicare.

FDA announced March 10 that it will withdraw and revise several COVID-19 guidance documents, including emergency use authorization of surgical masks, as circumstances surrounding the virus evolve.

The updated guidance highlights the importance of sustaining a QAPI program over time and increasing engagement by the hospital’s governing body.

The voluntary pledge asks institutions to commit to reducing emissions, taking inventory of scope 3 emissions, and developing climate resilience plans.

A bivalent vaccine that protects against SARS-CoV-2 and influenza will not be available this year, while a CDC advisory committee says there is not enough evidence to recommend more than one annual COVID-19 booster for immunocompromised people.

Two proposed rules would extend many flexible provisions enacted during the COVID-19 public health emergency for prescribing controlled substances.

States may start initiating Medicaid renewals between February and April and terminating enrollment for individuals who no longer qualify as early as April 1.

Applications close May 31 for the two-year extension of the Bundled Payments for Care Improvement Advanced voluntary payment model.

CMS proposes to limit the types of Medicaid Section 1115 waiver days that can be included when calculating a hospital’s disproportionate patient percentage.

FDA authorizes the first at-home nasal test that detects influenza A and B as well as COVID-19; Moderna reaches a $400 million agreement with the National Institutes of Health.

The proposed rule implements Section 203, which alters the process for calculating the Medicaid disproportionate share hospital uncompensated care limit.

The order instructs agencies to produce an annual public equity action plan, build agency equity teams, and improve community engagement.

The bulletin advises that arrangements among providers to redistribute Medicaid payments violate the hold harmless provisions of the law.

National Institutes of Health research finds that Black and Hispanic Americans face greater long COVID-19 risks, the CDC says that primary series vaccination protects children ages 3–5 for four months, and Novavax will deliver an additional 1.5 million doses.

The association asked that CMS swiftly make 340B hospitals whole for reduced Medicare Part B reimbursement from 2018 to fall 2022, plus applicable interest.

HHS instructed federal independent dispute resolution entities not to issue new payment determinations in out-of-network billing payment disputes.

The CDC updated the 2023 immunization schedule for children and adolescents to include the COVID-19 primary vaccine series, and the FDA cleared for commercial distribution a device that detects 15 respiratory viral and bacterial infections.

The roadmap outlines which policies implemented under the COVID-19 public health emergency (PHE) will be affected when the PHE ends May 11.

Drug manufacturers that increase prices faster than the inflation rate must pay rebates to Medicare; comments on this policy are due to CMS March 11.

Following the agenda's release, HHS on Feb. 10 requested information on promising practices for advancing health equity for intersex individuals.

FDA no longer requires a positive COVID-19 test to receive a Paxlovid or Lagevrio prescription; CDC reports that bivalent boosters protect against XBB and XBB.1.5 SARS-Co-V-2 subvariants.

The updated fact sheets share when specific waivers will end and whether they will continue after the public health emergency's end on May 11.

The guidance informs states how to maintain the temporary increased federal medical assistance percentage while returning to normal Medicaid operations.

Qualified individuals and their families who lose Medicaid or CHIP eligibility once the continuous enrollment requirement ends can apply for marketplace coverage between March 31, 2023, and July 31, 2024.

The Biden administration announced that the COVID-19 public health emergency, initially declared Jan. 27, 2020, will end May 11.

FDA's Vaccines and Related Biological Products Advisory Committee votes to replace the original monovalent COVID-19 vaccine, Evusheld no longer is authorized under emergency use, and the CDC launches a COVID-19 testing locator.

The Drug Enforcement Administration no longer will require additional registration for prescribers to prescribe buprenorphine.

CMS reports that open enrollment through the health insurance marketplaces for 2023 totals 16.3 million people, a 13 percent increase from 2022.

An FDA committee will vote on the future of the COVID-19 vaccine, while CDC unveils two trackers for COVID-19, flu, and RSV–related hospital and emergency department visits.

The association supports HHS' work to align the rule more closely with HIPAA regulations, which will improve care coordination and mitigate discrimination.

In a new podcast series by a physician at association member NYC Health + Hospitals, Beth Feldpush, DrPH, the association's senior vice president of policy and advocacy, unpacks the complex patchwork of payments that keep essential hospitals afloat. 

The National Institutes of Health launches the Home Test to Treat program; FDA and CDC report a COVID-19 vaccine safety concern for those ages 65 and older.

America's Essential Hospitals and other plaintiffs had asked the judge to order an immediate repayment in full for five years of underpayments to 340B hospitals.

A CMS letter to state Medicaid directors clarifies how in lieu of services (ILOS) can be used to mitigate health disparities, limits ILOS expenditures, and adopts documentation and review requirements.

The association supports CMS' work to simplify enrollment and asks the agency to ensure equitable access to beneficiaries’ preferred health care providers.

Prioritizing hospitals in health professional shortage areas, CMS awarded residency slots to 100 hospitals, including 27 essential hospitals.

Effective Jan. 11, Health and Human Services Secretary Xavier Becerra renewed the COVID-19 public health emergency determination.

FDA and CDC say Evusheld is unlikely to neutralize the XBB.1.5 subvariant, and a CDC report indicates COVID-19 vaccination in children and adolescents is highest among Asian and Hispanic youth. 

After the omnibus bill decoupled Medicaid redeterminations from the end of the COVID-19 public health emergency, CMS updates key redetermination dates.

Medicaid and CHIP coverage of interprofessional consultation is permissible as long as the consultation is for the beneficiary's direct benefit.

FDA approves the use of Actemra, a monoclonal antibody treatment, as COVID-19 cases caused by the XBB.1.5 subvariant of SARS-CoV-2 spike.

The report summarizes responses to a 2022 request for information, which focus on eligibility and enrollment, access to hospital services, and payment.

The proposed rule updates essential community provider requirements for qualified health plans and adds a special enrollment period for those disenrolled from Medicaid or CHIP.

Americans again can request four no-cost, at-home COVID-⁠19 tests per address; FDA's vaccine committee will meet in January to develop a long-term strategy.

A proposed rule will make permanent a temporary policy to allow providers to initiate buprenorphine prescriptions for new patients through telehealth.

The dashboard tracks nonfatal opioid overdoses by state and county and will help service providers target substance use disorder interventions and treatment.

CDC expands its recommendation for bivalent COVID-19 vaccines for children ages 6 months to 5 years old as health agencies confront low vaccination rates among children.

The proposed rule leverages application programming interfaces to exchange health information and automate the provider prior authorization process.

FDA pauses its emergency use authorization of bebtelovimab, which does not protect against prevalent SARS-CoV-2 subvariants; CDC updates its guidance for managing COVID-19 in congregate living settings to align with previous guidance.

The agency will not enforce a surprise billing requirement that requires good faith estimates to include cost estimates from co-providers and co-facilities.

The proposed administrative dispute resolution process delegates the majority of decision-making authority to Office of Pharmacy Affairs staff and has no minimum monetary threshold for claims.

The proposed rule aims to align Part 2 more closely with HIPAA, improve care coordination, and increase anti-discrimination protections for patients with substance use disorder.

New COVID-19 vaccine initiatives seek to address access inequalities, and NIH launches a website where Americans can self-report COVID-19 test results anonymously to provide data to public health departments.

The memo reviews regulatory obligations to care for patients in a safe environment, including the need to identify patients at risk for intentional harm to themselves or others.

Pfizer-BioNTech and Moderna data indicate that bivalent vaccines provide greater protection than the original monovalent vaccine against the emerging BQ.1.1 omicron subvariant, while the CDC reports low COVID-19 vaccination numbers among children.

The agency shared three sample formats to help hospital staff build machine readable files to comply with the Hospital Price Transparency Rule.

A JAMA Network open study highlights disparities in access to Test-to-Treat sites; the Biden administration holds a White House COVID-19 Equity Summit.

The CMS Innovation Center shares a progress report on its 10-year strategy and a blog post announcing plans to improve integrated specialty care.

A new report from the Department of Veterans Affairs indicates that Paxlovid can reduce risk of long COVID-19; new data show Pfizer bivalent COVID-19 booster vaccines substantially increase immune responses compared with monovalent vaccines.

The association urges CMS to educate and provide funding for essential hospital staff to conduct Medicaid and CHIP eligibility and enrollment activities.

The Medicare Outpatient Prospective Payment System final rule for calendar year 2023 reverses cuts to hospitals in the 340B Drug Pricing Program and delays developing a remedy for cuts to 340B hospitals that have been in place since 2018.

The rule finalizes the conversion factor and includes reimbursement provisions for telehealth and behavioral health services, the Quality Payment Program, and the Medicare Shared Savings Program.

President Joe Biden urges Americans to get their updated COVID-19 vaccine, which protects against the original SARS-CoV-2 variant and BA.4 and BA.5 subvariants.

Financial, educational, and workplace challenges pose obstacles to recruiting and retaining a diverse behavioral health workforce.

Currently, 26 states have extended Medicaid and Children's Health Insurance Program coverage from 60 days to 12 months postpartum.

A CDC committee recommends the inclusion of COVID-19 vaccines in the 2023 immunization schedule; the administration releases a biodefense strategy.

CDC recommends for younger age groups updated Pfizer and Moderna COVID-19 booster vaccines that target the BA.4 and BA.5 subvariants of SARS-CoV-2.

The decision to revert to the full payment rate is in compliance with a recent federal district court decision in favor of America’s Essential Hospitals.

CMS extends for two years the Bundled Payments for Care Improvement Advanced Model and alters the accounting process for beneficiaries with COVID-19.

Effective Oct. 13, Health and Human Services Secretary Xavier Becerra renewed the COVID-19 public health emergency determination.

HHS links COVID-19 vaccinations to fewer COVID-19 hospitalizations and deaths, and NIH details its plan to study long COVID-19 effects.

CDC issued a health advisory reminding health care providers to remain aware of a patient’s international travel history.

FDA now urges COVID-19 test developers to take traditional premarket review pathways, and HHS will cover the cost of 60,000 bebtelovimab doses.

In a new Forefront commentary, the association's current, immediate past, and incoming board chairs say essential hospitals’ indispensable role, unique characteristics, and financial fragility argue for recognizing them as a distinct class in public health and policymaking.

America's Essential Hospitals urges HHS to codify a nondiscrimination standard and establish nondiscrimination training for all health care workers.

A federal district court ruled that HHS must pay hospitals in the 340B Drug Pricing Program the full Medicare Part B drug payment rate for the remainder of calendar year 2022.

CDC updates guidance on infection control for health care personnel and staff shortages, as well as its global pandemic response strategy.

AHRQ published a primer detailing how hospitals and health systems can reduce their carbon footprint and protect communities from climate threats.

The roadmap implements the three pillars of the President's March 2022 Strategy to Address our National Mental Health Crisis.

CDC reports lower in-hospital mortality rates from the omicron variant, providers have until Sept. 30 to report period 3 Provider Relief Fund spending.

HHS seeks input on the No Surprises Act's advanced explanation of benefits and good faith estimate requirements for insured individuals; comments are due Nov. 15.

America's Essential Hospitals urges CMS to swiftly restore full Medicare Part B drug payment rates for hospitals in the 340B Drug Pricing Program and define a select group of hospitals with a safety net mission.

The Biden administration encourages organizations to commit to working toward its goal of ending hunger and increasing healthy eating and physical activity by 2030.

The Biden administration's fall plan to manage the COVID-19 pandemic includes securing millions of updated vaccines and additional at-home, rapid tests; ensuring vaccine access for higher-risk Americans; and fostering community conversations about updated vaccines.

The agency requests information on health care access and equity, provider experiences, and the effect of policies introduced in response to COVID-19.

The association urged CMS to adequately reimburse off-campus, provider-based departments; refine physician quality reporting; and codify a definition of essential hospitals.

A September continuing resolution provides a potential legislative vehicle for health policy provisions. We summarize key workforce priorities and actions from Congress, the administration, and the association.

CDC recommends updated Pfizer and Moderna COVID-19 booster vaccines that target the BA.4 and BA.5 subvariants of SARS-CoV-2.

An Aug. 31 CMS proposed rule aims to streamline Medicaid and CHIP enrollment and ensure continuous coverage throughout the renewal process.

CMS on Aug. 29 finalized its decision to delay indefinitely implementation of the Radiation Oncology Model, which was scheduled to start Jan. 1, 2023.

No-cost, at-home COVID-19 tests no longer will be offered through the United States Postal Service, CDC releases a fall vaccination plan, and FDA warns prescribers about Paxlovid drug interactions.

The Department of Homeland Security finalized a rule codifying the Deferred Action for Childhood Arrivals program with some limited changes.

The annual 340B Drug Pricing Program recertification period for hospitals began Aug. 24. Hospitals will have until Sept. 19 to complete the process.

Pfizer applies for emergency use authorization for its omicron-specific booster vaccine, the National Healthcare Safety Network will take over hospital data reporting, and CMS tells hospitals to brace for the public health emergency's end.

The rule finalizes disclosure requirements for the qualifying payment amount and select provisions for the related independent dispute resolution process.

CDC updated its COVID-19 safety guidelines, FDA warned of false negative test risks, and bebtelovimab will transition to the commercial marketplace.

HHS releases two new reports on long COVID-19 research and support, while the Administration for Strategic Preparedness & Response shares guidance on Paxlovid efficacy and eligibility.

The proposed rule expands the definition of discrimination "on the basis of sex" and explicitly includes telehealth services in nondiscrimination policies.

The declaration enables HHS to modify Medicare and Medicaid program requirements and could lead to more emergency funding for virus prevention and vaccines.

Health care providers have until Aug. 30 to download their preview reports before CMS shares quality data publicly in October.

The regulation contains payment and quality reporting provisions, a new designation to identify “birthing-friendly” hospitals, and a 4.3 percent increase in operating payment rates for general acute-care hospitals, compared with a proposed 3.2 percent update.

This is the second star ratings update since the agency updated its methodology in 2020 to include the use of peer grouping.

HHS agreed to purchase 66 million Moderna bivalent COVID-19 vaccine doses, while the CDC reported fewer vaccine reactions for those older than 50 who receive a second mRNA booster shot.

As the World Health Organization declares monkeypox a global health emergency, CDC updates clinical guidance, and HHS plans to allocate additional vaccine doses.

CDC recommends the Novavax COVID-19 vaccine for adults and reports that additional mRNA COVID-19 vaccine booster doses increase protection against moderate and severe COVID-19.

The Aug. 22 webinar will complement other federal resources on the annual 340B Drug Pricing Program recertification period for hospitals, open from Aug. 24 to Sept. 19.

The Department seeks comment on Public Service Loan Forgiveness program eligibility policies for physicians at nonprofit hospitals.

CMS seeks feedback at a July 21 listening session on the 5 percent lump sum Alternative Payment Model Incentive Payment, set to expire at the end of 2022. 

FDA approves the Novavax COVID-19 vaccine for those 18 and older as the Biden-Harris administration releases an action plan to take on the BA.5 subvariant.

The Medicare Outpatient Prospective Payment System proposed rule for calendar year 2023 reverses cuts to 340B Drug Pricing Program hospitals and seeks comment on remedying existing cuts to 340B hospitals.

Effective July 15, Health and Human Services Secretary Xavier Becerra renewed the COVID-19 public health emergency determination.

CMS proposes to decrease the conversion factor determining physician payment rates for specific services by $1.53. The proposed rule also includes provisions related to Medicare reimbursement of telehealth services, vaccine administration, and the Medicare Shared Savings Program.

FDA approves the Pfizer COVID-19 vaccine for use in individuals ages 12 to 15 and authorizes state-licensed pharmacists to prescribe Paxlovid.

Certain providers who returned Provider Relief Fund payments because they were unable to meet the period 1 reporting deadline can apply for reissuance of these funds.

The document outlines five priority goals to improve maternal health and outcomes and, for each, actions the federal government will take.

The GAO reviewed recent and planned actions to enhance oversight of state directed payments and found the effectiveness of these actions is unknown and information gaps remain.

The strategy aims to deploy vaccines rapidly in the most affected communities, facilitate testing, and engage stakeholders to mitigate spread.

The HHS Office of Climate Change and Health Equity announced a climate change webinar series, beginning July 14, and shared a companion resource compendium.

FDA advises vaccine manufacturers to incorporate an omicron variant component into booster doses; Pfizer requests FDA approval of antiviral pill Paxlovid.

CDC recommends the Moderna vaccine for kids ages 6 to 17; an FDA committee will consider modifying COVID-19 vaccine composition to reflect virus mutations.

CDC recommends that children ages 6 months to 5 years receive a COVID-19 vaccine; Pfizer study data shows Paxlovid failed to alleviate COVID-19 symptoms.

In a resounding victory for essential hospitals, the U.S. Supreme Court unanimously ruled in favor of America’s Essential Hospitals in its years-long legal challenge to restore full Medicare payment rates for 340B Drug Pricing Program hospitals.

The order instructs the HHS Secretary to use the agency's authorities to protect LGBTQI+ individuals' access to medically necessary care.

In its June report to Congress, the Medicaid and CHIP Payment and Access Commission considers oversight of managed care directed payments and examines Medicaid's role in advancing health equity.

The commission's June report to Congress includes illustrative policies about defining and supporting Medicare safety net providers and aligning payments across outpatient settings, among other topics of interest to essential hospitals.

The Supreme Court’s dismissal of the appeal does not touch on the legality of the public charge rule but only on the ability of the 13 states to intervene in defense of the rule.

America's Essential Hospitals commented on several policy proposals of interest to essential hospitals and responded to requests for information on maternal health, equity, and climate change.

The tool compiles existing guidance to help states prepare to return to regular Medicaid operations after the COVID-19 public health emergency ends.

CDC no longer requires a negative COVID-19 test or proof of COVID-19 recovery from travelers to the United States; an FDA advisory committee recommends the Novavax vaccine.

The National Steering Committee for Patient Safety calls on health care providers to put its 2020 Action Plan into practice.

Hospitals have until June 16 to preview their Overall Hospital Quality Star Rating, measure group score, and individual measure results, along with peer grouping.

An FDA advisory committee deliberates the safety of Novavax's COVID-19 vaccine and will consider amendments to Pfizer's and Moderna's authorization requests later this month.

The agency's strategy to strengthen behavioral health care focuses on improving access, equity, quality, and data integration.

FDA extended the shelf life of select lots of bebtelovimab and updated the authorization for Evusheld to include information about hypersensitivity risks.

CMS on May 25 approved proposals in four states to extend postpartum Medicaid coverage from 60 days to one year after birth.

A new advisory from U.S. Surgeon General Vivek Murthy, MD, MBA, calls for a whole-of-society approach to protect and support health workers facing burnout.

The webpage includes renewal instructions for eligible beneficiaries and guidance for ineligible beneficiaries to secure insurance through the marketplaces.

CDC is tracking monkeypox, a virus endemic to west and central Africa, after confirming a case in a Massachusetts resident who recently traveled to Canada.

A new CMS resource highlights federal requirements for program renewals, verifications, applications, and oversight amid the anticipated COVID-19 public health emergency unwinding.

Pfizer and BioNTech release promising data on a three-dose COVID-19 vaccine for children six months to younger than 5; CDC expands booster shot eligibility to include everyone 5 years old and older.

The current National Suicide Prevention Lifeline number, 1.800.273.8255, will transition to 988 on all devices on July 16.

The association urged HHS to provide funding, educate stakeholders, and build capacity to execute the 2022 Environmental Justice Strategy and Implementation Plan.

HHS urges governors to start planning for the end of the COVID-19 public health emergency; FDA authorizes a Pfizer booster vaccine for children ages 5 to 11.

New HHS initiatives focus on climate change, health equity, and the role health care stakeholders can play in promoting climate resilience.

FDA limits authorized use of the Janssen COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome following vaccination; a new analysis estimates vaccines are associated with $2.6 million in savings due to a reduction in Medicare hospitalizations.

A new omicron subvariant, BA.2.12.1, constitutes more than 30 percent of U.S. genomic sequences; Moderna files for emergency use authorization for a vaccine for children younger than 6.

The association thanked the administration for taking steps to reverse the damaging 2019 broadened definition of public charge and made recommendations for developing and implementing a new definition.

The final rule raises the essential community provider threshold from 20 to 35 percent and uses wait time standards to evaluate qualified health plans for network adequacy.

In a white paper, the association encourages CMS to develop policies that reduce disparities and incorporate equity into waiver approval and evaluation processes.

Moderna releases promising preliminary data on its variant-specific COVID-19 booster shot; CDC launches a Center for Forecasting and Outbreak Analytics.

The Accreditation Council for Graduate Medical Education introduced two rural track program designations to accredited residency programs and seeks members for an advisory group on health care access for medically underserved areas and populations.

Hospitals and other industry stakeholders are invited to pledge by June 3 to reduce greenhouse gas emissions and increase their climate resilience.

America's Essential Hospitals generally supports the tool, as it will direct investments to target several social determinants of health, but recommended the tool show aggregate data at the state and county levels.

The action plan includes goals to close gaps in health care access, quality, and outcomes through data collection, outreach, and community engagement.

The proposed fiscal year 2023 Inpatient Prospective Payment System rule would increase operating payment rates by 3.2 percent and make other changes to Medicare payment and quality reporting policies. CMS is accepting comments on the proposed rule until June 17.

The independent dispute resolution process can be initiated to resolve payment disputes between health care providers and issuers.

The association made recommendations on payment rates, workforce development, eligibility and enrollment policies, and measuring access to hospital services.

A federal judge in Florida ruled against the Centers for Disease Control and Prevention (CDC) travel mask requirement, ending the Transportation Security Administration's enforcement of the mandate. But the CDC continues to recommend masking during traveling.

Effective April 16, Health and Human Services Secretary Xavier Becerra renewed the public health emergency determination related to the continued effects of COVID-19; the determination has been in place since Jan. 27, 2020, and has been renewed every three months.

President Joe Biden announces a national research plan on prolonged illness developed after COVID-19; FDA limits authorization of sotrovimab to treat COVID-19.

Two new documents provide guidance for health care providers on No Surprises Act compliance and good faith estimates for uninsured or self-pay patients.

CMS shares tools to mitigate an anticipated increase in Medicaid fair hearing requests and resume normal operations after the COVID-19 public health emergency ends.

Recommendations for Medicare and Medicaid equity measures under development focus on standardized data collection and opportunities for testing and feedback.

CDC recommends an additional COVID-19 booster for older and immunocompromised adults; COVID.gov aggregates COVID-19 prevention and treatment tools; CDC data show threats to youth mental health during the pandemic.

FDA authorizes a second vaccine booster for older and immunocompromised individuals; OSHA reopens the comment period for its emergency temporary standard.

Research shows mRNA vaccines effectively prevent ventilation and death from COVID-19; Pfizer and Moderna seek authorization for an additional booster dose.

In its March report to Congress, the Medicaid and CHIP Payment and Access Commission examines the relationship between Medicaid disproportionate share hospital (DSH) allotments, uncompensated care costs, and services for low-income, uninsured populations.

Citing a depletion of funds for the HRSA COVID-19 Uninsured Program, the agency says the last day for providers to submit claims for testing and treatment is March 22 and the last day to submit vaccine administration claims is April 5.

The Transportation Security Administration extends to April 18 its public transit mask mandate; HHS shares a fact sheet on the COVID-19 Test-to-Treat initiative.

A State Health Official letter includes guidance for states to prepare for the COVID-19 public health emergency unwinding and return to regular Medicaid program operations.

The court ruled the qualifying payment amount should not be the main factor in determining payment for out-of-network services in independent dispute resolution.

President Joe Biden unveils a new COVID-19 National Preparedness Plan; FEMA extends its 100 percent federal cost share for COVID-19 efforts.

Coupled with the $11 billion previously distributed, this brings total phase 4 payments to about $11.5 billion, leaving less than $6 billion in pledged funds. These new funds will reach more than 4,000 providers across the United States this week.

CDC announces a new community-level framework that assesses COVID-19 risk; the Biden administration unveils a new COVID-19 mitigation plan for people with disabilities.

The Centers for Medicare & Medicaid Services outlines the application process for 1,000 new graduate medical education slots created by the Consolidated Appropriations Act of 2021. Applications for the first round of slots are due March 31, 2022, and CMS intends to award slots July 1, 2023.

The Center for Medicare & Medicaid Innovation will release a request for applications for the Realizing Equity, Access, and Community Health accountable care organization model, which will focus on promoting health equity and mitigating health disparities for underserved communities.

National emergency extended; new study highlights conditions and symptoms developed after COVID-19 infection; CDC updates vaccine guidance with clarifications for immunocompromised people.

Through a request for information, the Centers for Medicare & Medicaid Services hopes to better understand enrollees' barriers to coverage and access to care to inform future policies and regulatory actions. A 60-day public comment period began Feb. 17.

Authorization for the Pfizer COVID-19 vaccine for children six months to four years old is delayed; FDA authorizes the monoclonal antibody bebtelovimab.

Due to a calculation error in measure results used for calendar year 2021 public reporting, the Centers for Medicare & Medicaid Services has delayed until July the overall hospital star ratings update originally scheduled for April.

The Department of Health and Human Services will distribute $19.2 million in American Rescue Plan Act funds to help train primary care residents to provide quality care to diverse populations and communities, particularly in underserved and rural areas.

Pfizer and BioNTech apply for emergency use authorization for their pediatric COVID-19 vaccine; CDC recommends the Moderna COVID-19 vaccine; Medicare will cover over-the-counter COVID-19 tests.

FDA approves the Moderna COVID-19 vaccine and limits a monoclonal antibody authorization; OSHA withdraws its vaccine mandate emergency temporary standard.

An estimated 5.8 million people newly gained coverage during this open enrollment period; 32 percent of consumers using the federal marketplace selected a plan that costs them $10 or less per month. Enrollment remains open through Jan. 31 in five states and the District of Columbia.

Each awardee will receive up to $1.5 million for a three-year period to reduce the number of uninsured children by advancing Medicaid and Children's Health Insurance Program enrollment and retention. Grant applications are due March 28.

The funds will reach more than 7,600 providers across the country this week; $6 billion in pledged phase 4 funds remain undistributed.

The Biden administration will distribute 400 million no-cost N95 masks; CDC studies highlight the importance of boosters in protecting against COVID-19.

HHS awarded $103 million to improve health care worker retention by reducing staff burnout and promoting mental wellness. Several essential hospitals were among the awardees, including the University of New Mexico, Virginia Commonwealth University, and the University of Utah.

In response to the proposed rule for the 2023 plan year, the association urged the Department of Health and Human Services to ensure equitable access, finalize nondiscrimination policies, standardize collection of Z codes, and prorate premiums and advanced premium tax credits.

The U.S. Supreme Court upheld CMS' vaccine mandate but struck down the Occupational Safety and Health Administration's mandate; President Joe Biden announced new initiatives to expand testing access.

Effective Jan. 14, Health and Human Services Secretary Xavier Becerra renewed the public health emergency determination related to the continued effects of COVID-19; the determination has been in place since Jan. 27, 2020, and has been renewed every three months.

CDC shortens the time between primary vaccine series and booster shot and recommends a Pfizer booster for adolescents; the Supreme Court hears oral arguments on two vaccine mandates; HHS requires coverage of at-home COVID-19 tests, effective Jan. 15.

The Centers for Medicare & Medicaid Services released guidance and example templates for good faith estimates and the surprise billing patient-provider dispute resolution process.

The Medicare Part B drug model, also known as the most favored nation model, would have phased-in reduced payment rates for 50 Part B drugs over four years. America's Essential Hospitals previously called on CMS to withdraw the model.

The guidance results in a net reduction of about 30 percent of data fields; it adds questions on pediatric data, as well as makes mandatory certain influenza fields. The HHS guidance does not satisfy the requirements of a CMS quality measure on health care personnel vaccination rates.

FDA expands authorization for the Pfizer COVID-19 booster; FDA authorizes two antiviral pills; CMS updates guidance on vaccine mandate compliance.

New guidance from the Centers for Medicare & Medicaid Services reviews the timeline for open negotiations and initiating the federal independent dispute resolution process under the No Surprises Act.

The new document explains various provisions under part II surprise billing regulations, including that all financial assistance should be reflected in the good faith estimate regardless of the amount or type of discount. The new regulations take effect Jan. 1, 2022.

In the new rule, the agency finalizes proposals on direct and indirect graduate medical education (GME) policies in response to the COVID-19 pandemic and solicits comments on other GME issues to inform future policymaking.

The association asked that CMS provide additional time for hospitals to comply with the requirements, especially given the uncertain outcome of pending litigation regarding the administration's vaccine mandate.

CDC recommends mRNA COVID-19 vaccines be given clinical preference over the Janssen vaccine; the CMS vaccine mandate rule is revived in 25 states.

In a new white paper, America's Essential Hospitals discusses essential hospitals' role in value-based payment models and makes recommendations to the Center for Medicare and Medicaid Innovation on improving equity through broader model participation.

Providers now have until Dec. 20 to report lost revenue and expense information related to the receipt of Provider Relief Fund payments.

FDA authorizes the Pfizer COVID-19 vaccine booster for individuals as young as 16; the agency also authorizes a monoclonal antibody for COVID-19 prevention.

A Centers for Medicare & Medicaid Services letter to state Medicaid directors outlines new supplemental payment reporting and Medicaid disproportionate share hospital requirements under the Consolidated Appropriations Act.

The Substance Abuse and Mental Health Services Administration will ask grant recipients to develop or expand evidence-based services that may include the provision of sterile syringes, safe-sex kits, prevention education, overdose prevention kits, and more. Applications are due Feb. 7, 2022.

The advisory aims to combat the youth mental health crisis that worsened due to the COVID-19 pandemic. Specifically, the surgeon general recommends health care professionals focus on prevention and trauma-informed care principles, routinely screen children for mental health risk factors, and more.

In its comments to the Agency for Healthcare Research and Quality, the association stressed the importance of considering hospital physical infrastructure and financial status in developing research and practice improvement strategies.

As part of Vice President Kamala Harris' call to reduce maternal mortality and morbidity, a Department of Health and Human Services report highlights the impact of extending postpartum Medicaid coverage. In addition, CMS intends to propose a "Birthing-Friendly" hospital designation.

Vice President Kamala Harris hosted the first federal Maternal Health Day of Action. Coinciding with the event, America's Essential Hospitals announced 12 member hospitals will participate in a new CVS Health Foundation–funded learning collaborative to improve maternal health.

America’s Essential Hospitals commented on the second interim final rule implementing the No Surprises Act. The association urged HHS to revise good faith estimate requirements and create an IDR process that does not favor payers over providers.

As the omicron SARS-CoV-2 variant reaches the United States, President Joe Biden releases a new plan to combat COVID-19; CMS will not enforce its health care worker vaccine mandate amid legal challenges.

CMS released guidance to help states maintain Medicaid and Children's Health Insurance Program coverage as they return to normal operations when the COVID-19 public health emergency ends. Many strategies in the documents require support from outside organizations that work with beneficiaries.

A new Department of Health and Human Services report finds the share of Medicare visits conducted via telehealth increased from about 840,000 in 2019 to 52.7 million in 2020. In particular, telehealth was helpful in offsetting potential foregone behavioral health care during the COVID-19 pandemic.

The World Health Organization Nov. 26 classified a new COVID-19 variant, B.1.1.529, referred to as omicron. The variant was first reported in South Africa. To date, no cases have been identified in the United States.

The Department of Health and Human Services announced a $1.5 billion investment to help grow and diversify the nation's health care workforce through loan repayment and scholarship programs.

The proposed rule aims to strengthen and preserve the Deferred Action for Childhood Arrivals policy, which is critical to the nation's health care workforce. The association urges the Department of Homeland Security to formally add the policy through the notice-and-comment rulemaking process.

FDA and CDC endorse expanded eligibility for Pfizer and Moderna COVID-19 booster vaccine doses; Pfizer seeks authorization for its COVID-19 antiviral pill.

The Department of Health and Human Services released a fourth interim final rule to implement the No Surprises Act. The agency aims to enhance transparency and provide insight into how prescription drugs contribute to the growth of health care spending and the cost of health coverage.

CMS released final guidance for compliance with Medicare conditions of participation related to co-location, which occurs when two Medicare-certified hospitals or a Medicare-certified hospital and another health care entity are on the same campus or in the same building and share resources.

The Presidential Health Equity Task Force released recommendations for equitable disbursement of COVID-19 relief funds and culturally aligned communication to people of color and other underserved populations. Meanwhile, the White House announced $785 million in new investments to improve on equity.

Pfizer and BioNTech ask the FDA to authorize their COVID-19 booster vaccine for everyone age 18 and older; FEMA COVID-19 funding will continue until April 2022.

The letter from America’s Essential Hospitals to the Senate Committee on Finance responded to the panel’s request for information on improving access to and enhancing mental and behavioral health care.

CDC recommends the Pfizer COVID-19 vaccine for children ages 5 to 11; CMS holds a stakeholder call on its vaccine mandate for health care workers. Pfizer says its investigational novel COVID-19 oral antiviral candidate significantly reduces hospitalization and death.

CMS announced phased vaccination requirements as a condition of participating in Medicare and Medicaid; vaccination must be completed by Jan. 4, 2022. A new Occupational Safety and Health Administration emergency temporary standard promotes vaccination for businesses with 100 or more employees.

The rule adjusts the conversion factor used to determine physician payment rates and includes provisions related to appropriate use criteria, Medicare reimbursement for telehealth services, vaccine payment rates, the Quality Payment Program, and the Medicare Shared Savings Program.

The Medicare Outpatient Prospective Payment System final rule for calendar year 2022 continues cuts to hospitals in the 340B Drug Pricing Program and pauses elimination of the inpatient-only list. The rule also includes provisions on price transparency, rural emergency hospitals, and health equity.

FDA authorizes the Pfizer COVID-19 vaccine for use in children ages 5 to 11 and delays approval of the Moderna vaccine in adolescents ages 12 to 17. The agency recommends providers avoid purchasing or using imported medical gloves from certain companies that might be in violation of laws and rules.

The new strategy from the Department of Health and Human Services expands the scope of crisis response beyond opioids to include other substances often involved in overdoses. It focuses on four priority areas: primary prevention, harm reduction, evidence-based treatment, and recovery support.

The plan — required by the Coronavirus Aid, Relief, and Economic Security Act — focuses on increasing the health workforce in rural and underserved areas and better preparing for the health care needs of the future. HHS will issue a report to Congress on implementation.

Consumers now can preview health plans and prices on healthcare.gov ahead of open enrollment, which runs Nov. 1, 2020, through Jan. 15, 2021.

FDA and CDC recommend Moderna and Janssen booster vaccines, along with heterologous booster doses; the Biden administration releases a plan to vaccinate children.

America's Essential Hospitals submitted comments on the Department of Homeland Security advanced notice of proposed rulemaking on the public charge ground of inadmissibility. Following feedback, the agency plans to engage in the rulemaking process to issue an updated public charge regulation.

America's Essential Hospitals urged CMS to finalize withdrawal of the Trump administration's Most Favored Nation Model, citing procedural deficiencies, ongoing legal challenges, and significant reduction in provider payment rates.

A new Center for Medicare and Medicaid Innovation white paper outlines a strategy to advance health system transformation. The goal is to achieve equitable outcomes by driving accountable care, advancing health equity, supporting innovation, addressing affordability, and creating partnerships.

CMS will require states to cover COVID-19 treatment with no cost-sharing for Medicaid and Children's Health Insurance Program beneficiaries. Further, states in some circumstances must cover treatments for conditions that might seriously complicate the treatment of COVID-19.

In a letter to congressional leaders, America's Essential Hospitals advocates for strengthening the health care workforce in the wake of COVID-19, including through more funding in public health emergencies, prioritized visas for foreign clinicians, and increased graduate medical education slots.

The Vaccines and Related Biological Products Advisory Committee endorses booster shots of the Moderna and Janssen COVID-19 vaccines. Meanwhile, FDA delays authorization of the Moderna COVID-19 vaccine for emergency use in adolescents ages 12 to 17 after reports of cardiac side effects.

Money from the American Rescue Plan will fund up to 50 awards through the Health Resources and Services Administration's State Loan Repayment Program for state-run programs that support, recruit, and retain primary care clinicians who work in underserved communities.

Effective Oct. 18, Health and Human Services Secretary Xavier Becerra renewed the public health emergency (PHE) determination related to the continued effects of COVID-19. The PHE determination has been in place since Jan. 31, 2020.

A new analysis finds annual clinical labor costs in the emergency department and intensive care unit and among nursing staff increased by $24 billion due to the COVID-19 pandemic, translating to about $17 million in additional expenses for the average 500-bed facility.

The Department of Homeland Security will use the notice-and-comment rulemaking process to codify the Deferred Action for Childhood Arrivals program.

HHS released a Spanish version of QuestionBuilder, an app that helps patients and caregivers prepare for their in-person or telehealth appointments, along with a report on Latino patients' access to care.

The use of Z codes to document social determinants of health in Medicare fee-for-service beneficiaries increased slightly from 2017 to 2019 but remains low.

An HHS report shows the COVID-19 vaccine prevented hospitalization and death in Medicare beneficiaries; Pfizer applies for emergency use authorization for its vaccine in children age 5 to 11.

HHS guidance clarifies how HIPAA applies to COVID-19 vaccination status requests; CDC urges pregnant people to get vaccinated amid a surge in hospitalizations.

The departments of Health and Human Services (HHS), Treasury, and Labor and the Office of Personnel Management issued Part II of the No Surprises Act interim final rule with comment period.

FDA on Sept. 22 authorized a third booster dose of the Pfizer-BioNTech COVID-19 vaccine for select groups. A CDC panel subsequently recommended the booster shots, and CMS announced coverage for all Medicare beneficiaries and nearly all Medicaid and Children's Health Insurance Program beneficiaries.

In a Sept. 20 letter, America's Essential Hospitals welcomes the announcement of additional COVID-19 relief funding but notes the methodology falls short of adequate support for safety net providers. The association urges HHS to issue another targeted safety net distribution, among other requests.

An FDA advisory committee recommends a Pfizer COVID-19 vaccine booster for a limited population; CDC announces $2.1 billion dedicated to infection control and prevention.

The rule, released by the Department of Health and Human Service and the Department of Treasury, extends open enrollment, adds a new special enrollment period, expands navigator responsibilities, and modifies Section 1332 innovation waivers.

The calendar year 2022 Physician Fee Schedule proposed rule includes provisions on Medicare payment for telehealth services, the Quality Payment Program, and more. The association also responded to a request for information on improving health equity through data collection.

In response to the calendar year 2022 Outpatient Prospective Payment System proposed rule, America's Essential Hospitals urged CMS to halt elimination of the inpatient-only list and to restore adequate payment to hospitals in the 340B program and to off-campus provider-based departments.

In this first white paper of a new series, America's Essential Hospitals discusses the chronic underfunding of Medicaid as a form of structural racism and provides recommendations to ensure the program is an effective tool to improve equity.

The comprehensive plan includes potential legislative and administrative actions that could be used to lower drug prices. The plan also notes the importance of the 340B Drug Pricing Program and its role in supporting the health care safety net.

The president's newly announced "Path out of the Pandemic" plan includes action steps for increasing vaccinations, further protecting those who are vaccinated, keeping schools safely open, testing and mask requirements, and economic recovery. CDC updates its infection control guidance.

Hospitals have until Sept. 13 to complete 340B Drug Pricing Program recertification through the Office of Pharmacy Affairs Information System.

An FDA committee will review Pfizer's COVID-19 vaccine booster application; Moderna is applying for booster approval. CDC data show COVID-19 hospitalizations on the rise among children.

In a letter to the Centers for Medicare & Medicaid Services, America's Essential Hospitals commented on the first interim final rule implementing the No Surprises Act. The association urged HHS to delay implementation until after the COVID-19 public health emergency, among other requests.

In a letter to Democratic congressional leadership, the association urges consideration of essential hospital priorities — including funding for critical workforce and hospital infrastructure needs and protecting the 340B Drug Pricing Program — in forthcoming budget reconciliation legislation.

A CDC advisory committee voted Aug. 30 to recommend the Pfizer-BioNTech COVID-19 vaccine; the agency warns against using ivermectin to treat or prevent COVID-19.

In a letter to HHS Secretary Xavier Becerra, America's Essential Hospitals urges the agency to swiftly allocate and target remaining PRF funds, take steps to ensure adequate hospital staffing, expedite full approval of COVID-19 vaccines, and protect the nation's supply chain.

The Department of Homeland Security released an advance notice of proposed rulemaking to gather data and feedback on the public charge ground of inadmissibility. Public comments are due Oct. 22; DHS will host public listening sessions on Sept. 14 and Oct. 5.

FDA approves the Pfizer-BioNTech COVID-19 vaccine. HHS plans to promote a booster shot of the mRNA vaccines beginning in September. CMS and CDC work to develop an emergency regulation requiring COVID-19 vaccination for nursing home staff.

The Office of the National Coordinator for Health Information Technology will host a series of webinars to discuss information sharing requirements finalized in a 2020 rule. The first webinar, focused on clinicians, will be Sept. 14, from 1–2 pm ET. 

America's Essential Hospitals sent CMS recommendations for implementing the new Medicaid supplemental payment reporting system under the Consolidated Appropriations Act of 2020. The association noted the importance of accuracy and avoiding duplicate data collection.

America's Essential Hospitals outlines concerns with the timeline for implementation and the scope of the Occupational Safety and Health Administration's emergency temporary standard (ETS) for occupational exposure to COVID-19.

FDA and CDC recommend a third mRNA COVID-19 vaccine dose for immunocompromised people; CDC recommends COVID-19 vaccines for pregnant and breastfeeding people.

In an Aug. 13 letter to state health officials, the Centers for Medicare & Medicaid Services updates its guidance regarding the resumption of normal state Medicaid, Children’s Health Insurance Program, and Basic Health Program operations when the COVID-19 public health emergency ends.

The White House COVID-19 Response Team will host an Aug. 23 virtual conversation on increasing vaccination in an equitable way. The event is open to health system leaders and health care providers.

Two CDC studies highlight the effectiveness of the COVID-19 vaccines in preventing reinfection and hospitalization; CDC extends the eviction moratorium.

CMS proposes to rescind the Trump administration’s Most Favored Nation model interim final rule, which aimed to reduce payment for 50 Medicare Part B drugs. America’s Essential Hospitals previously urged the agency to withdraw the model due to substantive and procedural issues.

CMS on Aug. 2 released its fiscal year 2022 Inpatient Prospective Payment System final rule, which includes payment and quality reporting provisions. The rule does not finalize provisions related to new residency slots, organ acquisition costs, or Section 1115 waiver days. 

The annual 340B Drug Pricing Program recertification period for hospitals will begin Aug. 16. Hospitals will have until Sept. 13 to complete the process.

CDC recommends everyone, even those who are fully vaccinated, wear a mask indoors in public in areas with substantial and high COVID-19 transmission.

Effective Jan. 1, 2021, hospitals are required to publish standard charges, including negotiated rates, for all services in a machine-readable format. The Centers for Medicare & Medicaid Services will host a webinar on Aug. 11 for hospitals to learn about posting standard charge information.

As COVID-19 cases rise, the association calls on members to require employee vaccination; CDC urges immunocompromised people to continue wearing masks.

CMS released an advisory alerting certain qualifying participants in alternative payment models that the agency does not have billing information needed to disburse incentive payments. Participants who anticipated but have not received an incentive payment should submit the necessary form by Nov. 1.

Effective July 20, Health and Human Services Secretary Xavier Becerra renewed the public health emergency (PHE) determination related to the continued effects of COVID-19. The PHE determination has been in place since Jan. 31, 2020, and has been renewed every three months since.

The administration has created a new website, StopRansomware.gov, to help government agencies and the private sector understand the threat of ransomware, mitigate risk, and learn how to respond to a ransomware attack.

A bulletin from the Center for Medicaid and CHIP Services notes the withdrawal of the 2019 public charge rule and addresses states' role in safeguarding applicant and beneficiary information. The public charge rule was vacated and is no longer in effect, retroactive to March 2, 2021.

The OPPS proposed rule would continue cuts to hospitals in the 340B Drug Pricing Program and off-campus provider-based departments, pause the elimination of the inpatient-only list, and increase penalties for failing to report standard charges.

HRSA announced $103 million in American Rescue Plan funding over three years to help reduce burnout and promote mental health among the health care workforce.

The U.S. Surgeon General issues a health misinformation advisory; CDC and the Office of Minority Health develop a Minority Health Social Vulnerability Index.

CMS announces $15 million for state Medicaid agencies to launch mobile crisis intervention services, as authorized by the American Rescue Plan.

The rule includes provisions related to telehealth, vaccine payment rates, the Quality Payment Program, and the Medicare Shared Savings Program; comments are due to CMS by Sept. 13.

The Aug. 11 webinar will complement other federal resources on the annual 340B Drug Pricing Program recertification period for hospitals, which is scheduled to start Aug. 16. Hospitals will have until Sept. 13 to complete the process.

Notable to essential hospitals, the Biden administration's July 9 executive order includes health care items related to prescription drugs, price transparency, hospital consolidation, and health insurance.

The Occupational Safety and Health Administration extends to Aug. 20 the comment period for the COVID-19 health care emergency temporary standard. The Centers for Disease Control and Prevention and the Food and Drug Administration say fully vaccinated individuals do not need COVID-19 booster shots.

The Department of Health and Human Services announced $250 million in grant awards to 73 local governments as part of a new initiative to identify and implement best practices for improving health literacy to enhance COVID-19 vaccination among underserved populations.

On July 1, the Biden administration released part 1 of the No Surprises Act interim final rule. Passed as part of the Consolidated Appropriations Act of 2021, the rule establishes new patient protections from balanced billing and excessive cost-sharing, known as surprise billing.

The Supreme Court’s decision to review the case marks a significant step in the association’s efforts to overturn harmful Medicare Part B cuts to hospitals in the 340B Drug Pricing Program. The Supreme Court will hear oral arguments in the case in its next term, with a decision likely in 2022.

Providers who received Provider Relief Fund dollars and are required to document their use during reporting period 1 (April 10–June 30, 2020) have until Sept. 30 to access the portal and submit the information.

The departments of the Treasury and Health and Human Services proposed extending open enrollment in the Affordable Care Act marketplaces, adding a new special enrollment period, expanding navigator responsibilities, and modifying Section 1332 innovation waivers.

America's Essential Hospitals commented on several policy proposals of interest to essential hospitals in the Inpatient Prospective Payment System rule and responded to a request for information on closing the health equity gap in hospital quality programs.

CDC extends to July 31 the eviction moratorium to protect people unable to make rental payments due to the COVID-19 public health emergency. Distribution of bamlanivimab and etesevimab is paused after tests find they are ineffective against some COVID-19 variants.